Showing 93 results

Filters Content type: News, Editors' picks Country: Peru
Undetectable viral load & treatment as prevention

With Immediate Treatment of HIV, Semen Viral Load Drops Rapidly, Reports Small Study

Editor's pick
TheBodyPro
18 January 2024
Conference announcements & declarations

HIVR4P, the HIV Research for Prevention Conference, postponed until 2024

Editor's pick
International AIDS Society (IAS)
8 February 2023
PrEP programmes & uptake

Preexposure Prophylaxis Gives Good Results in Latin America

Editor's pick
Medscape (requires free registration)
23 January 2023
Conference announcements & declarations

HIVR4P, world’s most important HIV prevention conference, to take place in Lima and virtually in October 2023

Editor's pick
International AIDS Society
1 November 2022
Transgender people

Injectable PrEP is just as effective for transgender women as it is for gay men, study analysis finds

News
11 August 2022
Confidentiality, consent & medical ethics

“Why are we being used like guinea pigs?” Transgender women’s mistrust of PrEP research

News
20 October 2021
Opportunistic infections

Opportunistic infections remain common in people taking HIV treatment in Latin America

News
7 July 2020
Ethnic & cultural minorities

‘Geography is a problem’: slowing the silent spread of HIV in the Amazon

Editor's pick
The Guardian
11 November 2019
Epidemiology & behaviour

High and increasing HIV incidence in young Latin American gay men

News
8 August 2019
PrEP programmes & uptake

Same-day initiation of PrEP feasible and safe in Latin America

News
30 July 2019
Transgender people

Providing care for trans women with HIV/AIDS in Peru

Editor's pick
The Lancet (free registration required)
5 April 2019
Transgender people

Partners of transgender women form a separate HIV risk group, Peruvian study finds

News
22 March 2019
Migrants, refugees & displaced people

'I came to Peru to survive': Venezuelans migrating for HIV drugs

Editor's pick
The Guardian
24 February 2019
PrEP programmes & uptake

Cocaine use associated with poor adherence to PrEP and dropping out of care

News
22 February 2019
TB treatment

Higher doses of rifampin appear more effective in fighting TB without increasing risk of adverse events

Editor's pick
Eurekalert Inf Dis
29 June 2018
PrEP

PrEP in the Wild — A whirlwind tour of the who, what, where and how of PrEP use and provision outside of approval

Editor's pick
AVAC
5 May 2016
PrEP

Gilead Statement on the Approval of PrEP in Peru

Editor's pick
Gilead Sciences
14 April 2016
PrEP science

‘On-demand’ rectal microbicide gel has reasonable tolerability and acceptability – daily less so

News
28 February 2016
TB diagnosis

Low implementation of Xpert MTB/RIF among adults with HIV/TB co-infection in 19 low- and middle-income countries

News
21 December 2015
Drug-resistant TB

Multidrug-resistant TB appears less transmissible in households than drug-susceptible TB

Editor's pick
Eurekalert Inf Dis
24 June 2015
Activism & civil society

Peru: Patients Demand End to Monopoly on HIV Medication

Editor's pick
TeleSUR
21 January 2015
PrEP science

Overall PrEP effectiveness in iPrEx OLE study 50%, but 100% in those taking four or more doses a week

News
22 July 2014
Nutrition

Low vitamin D concentrations associated with poor clinical and virological outcomes among people starting HIV therapy

News
19 May 2014
Clinical trials

Thanks for Nothing: iPrEX Volunteers Shut Out of PrEP’s Success

Editor's pick
Poz
6 May 2014